ICCM - IceCure to get patent in Japan for cryogenic pump

• IceCure Medical ( NASDAQ: ICCM ) said it received a Notice of Allowance from the Japan Patent Office (JPO) for its novel cryogenic pump for cryoablation systems.
• The patent titled 'Cryogen Pump' will be in effect until 2041.
• A patent for this invention has already been issued in the EU and is pending in other major markets, including the U.S, the company added.
• The cryogenic pump is submersible in liquid nitrogen, improves the cooling rate during a procedure, and can be used for multiple procedures or longer duration procedures without the need to refill liquid nitrogen, according to the company.
• "This additional IP in Japan supports our distribution agreement with Terumo for our cryoablation systems in Japan," said IceCure's CEO Eyal Shamir.

For further details see: